Daewoong Pharmaceutical Successfully Hosts 'Violet Launch Symposium Busan' for Submental Fat Reduction Injection

The Only MFDS-Approved in Korea... Safety Proven
Spreading Violette Procedure and More to Medical Professionals

'Violet Launching Symposium Busan' held at Lotte Hotel Busan on the 12th-13th of this month

[Asia Economy Reporter Lee Gwan-joo] Daewoong Pharmaceutical held an event to promote the excellence and procedure methods of 'V-OLET,' a submental fat reduction injection developed in-house.

Daewoong Pharmaceutical announced on the 15th that it held the 'V-OLET Launch Symposium Busan' at Lotte Hotel Busan on the 12th and 13th. About 50 medical professionals participated in this symposium.

The symposium, held consecutively in Seoul and Busan, was organized to commemorate the launch of V-OLET, the only submental fat reduction injection approved in Korea, allowing medical professionals to academically understand V-OLET and learn various procedure methods.

Daewoong Pharmaceutical shared the academic knowledge necessary for V-OLET procedures through frontline medical professionals in each field. Professor Han Seung-ho of Ewha Womans University College of Medicine gave a lecture on ‘Clinical Anatomy of Submental Region,’ introducing anatomical knowledge of the submental area, which medical professionals are most curious about. Professor Lee Yang-won of Konkuk University Hospital Dermatology Department led the session on ‘V-OLET Phase 3 Clinical Results and Case Review,’ reviewing the submental fat reduction effects and safety of V-OLET based on actual clinical data and cases.

Submental Fat Reduction Injection 'Violet' Package and Vial

A session was also provided where expert medical professionals taught actual procedure methods. Director Kim Ja-young of Rinovo W Clinic gave a lecture on ‘Clinical Consideration of V-OLET and Understanding of Combination Procedures,’ sharing the situations where V-OLET is needed and know-how in actual procedures. Director Choi Won-seok of V Plastic Surgery Clinic also shared know-how on combination procedures with medical devices that can create synergy with V-OLET, such as high-intensity focused ultrasound (HIFU), through his lecture on ‘Combination Procedure Know-how for Submental Fat Reduction.’

Park Sung-soo, Vice President of Daewoong Pharmaceutical, said, “V-OLET is Daewoong Pharmaceutical’s second medical aesthetic lineup confidently launched after being the first in Asia to receive FDA approval,” adding, “We will do our best to actively share the correct procedure methods of V-OLET to ensure safe and effective treatments.”

Launched in October last year, ‘V-OLET’ is the only submental fat reduction injection officially approved by the Ministry of Food and Drug Safety in Korea. It features a distinctive effect that lasts long by irreversibly destroying fat cells. Daewoong Pharmaceutical plans to further solidify its position in the medical aesthetic industry with V-OLET following its botulinum toxin ‘Nabota.’

This content was produced with the assistance of AI translation services.